87436-2
Chromosome X and Y aneuploidy in Blood or Tissue by FISH
Active
Term Description
Sex chromosome (X & Y) analysis by FISH to determine gender (XY or XX) or presence of aneuploidy in blood or tissue-type specimens, including cheek (buccal) swabs or saliva. For aneuploidy cases, the results of the specific findings (e.g. YY, XYY, XXX, etc.) are reported as well. This document may contain the reason for referral, the specimen source, the overall result (normal/abnormal), the result in ISCN expression (e.g. nuc ish(DXZ1x2)[200]), the interpretation or findings, recommendations, and test method information.
Source: Regenstrief LOINC
Part Descriptions
LP187145-0 Chromosome X & Y aneuploidy
Sex chromosome aneuploidy is a condition in which there are extra or missing X or Y chromosomes. Typically, a female has two X chromosomes (XX) and a male has one X and one Y (XY). Examples of sex chromosome aneuploidies include XXX, XXY, XYY, and XO (presence of only one sex chromosome). Each of these aneuploidies may be associated with different clinical syndromes.
Source: Regenstrief LOINC
LP62864-1 FISH
FISH (fluorescence in situ hybridization) is a cytogenetic technique used to detect and localize the presence or absence of specific DNA sequences on chromosomes. FISH uses fluorescent probes that bind to only those parts of the chromosome with which they show a high degree of sequence similarity. Fluorescence microscopy can be used to find out where the fluorescent probe bound to the chromosomes. FISH is often used for finding specific features in DNA for use in genetic counseling, medicine, and species identification. FISH can also be used to detect and localize specific mRNAs within tissue samples. In this context, it can help define the spatial-temporal patterns of gene expression within cells and tissues.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, FISH
Fully-Specified Name
- Component
- Chromosome X & Y aneuploidy
- Property
- Find
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Doc
- Method
- FISH
Additional Names
- Short Name
- Chr X + Y aneup Bld/T FISH
- Display Name
- Chr X and Y aneuploidy FISH Doc (Bld/Tiss)
- Consumer Name Alpha Get Info
- Chromosome X and Y Aneuploidy, Blood or tissue specimen
Associated Observations
81247-9 Master HL7 genetic variant reporting panel
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
81247-9 | Master HL7 genetic variant reporting panel | |||
Indent81306-3 | Variables that apply to the overall study | |||
Indent Indent53577-3 | Reason for study | O | 0..* | |
Indent Indent51967-8 | Genetic disease assessed [ID] | O | 0..* | |
Indent Indent51963-7 | Medication assessed [ID] | C | 0..* | |
Indent Indent48018-6 | Gene studied [ID] | C | 0..* | |
Indent Indent36908-2 | Gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal | C | 0..* | |
Indent Indent51959-5 | Range(s) of DNA sequence examined | C | 0..* | |
Indent Indent81293-3 | Description of ranges of DNA sequences examined | C | 0..1 | |
Indent Indent51968-6 | Discrete variation analysis overall interpretation | R | 1..1 | |
Indent Indent83006-7 | Deletion-duplication overall interpretation | C | ||
Indent Indent51969-4 | Genetic analysis report | O | 0..1 | |
Indent Indent81291-7 | Variant ISCN | C | ||
Indent Indent62374-4 | Human reference sequence assembly version | C | 0..1 | |
Indent Indent81303-0 | HGVS version [ID] | O | 0..1 | |
Indent Indent82115-7 | dbSNP version [ID] | O | 0..1 | |
Indent Indent83007-5 | COSMIC version [ID] | O | ||
Indent Indent83008-3 | ClinVar version [ID] | O | ||
Indent81250-3 | Discrete genetic variant panel | 0..n | ||
Indent Indent83005-9 | Variant category | |||
Indent Indent81252-9 | Discrete genetic variant | C | 0..1 | |
Indent Indent48018-6 | Gene studied [ID] | C | 0..1 | |
Indent Indent51958-7 | Transcript reference sequence [ID] | C | 0..1 | |
Indent Indent48004-6 | DNA change (c.HGVS) | C | 0..1 | |
Indent Indent48005-3 | Amino acid change (pHGVS) | C | 0..1 | |
Indent Indent48019-4 | DNA change type | O | 0..1 | |
Indent Indent48006-1 | Amino acid change [Type] | O | 0..1 | |
Indent Indent48013-7 | Genomic reference sequence [ID] | C | 0..1 | |
Indent Indent81290-9 | Genomic DNA change (gHGVS) | C | ||
Indent Indent69547-8 | Genomic ref allele [ID] | C | 0..1 | |
Indent Indent81254-5 | Genomic allele start-end | C | 0..1 | |
Indent Indent69551-0 | Genomic alt allele [ID] | C | 0..1 | |
Indent Indent84414-2 | Haplotype name | O | ||
Indent Indent81255-2 | dbSNP [ID] | O | 0..1 | |
Indent Indent81257-8 | CIGAR [ID] | O | 0..1 | |
Indent Indent48001-2 | Cytogenetic (chromosome) location | O | 0..1 | |
Indent Indent48002-0 | Genomic source class [Type] | O | 0..1 | |
Indent Indent81304-8 | Variant analysis method [Type] | O | ||
Indent Indent53037-8 | Genetic variation clinical significance [Imp] | O | 0..1 | |
Indent Indent69548-6 | Genetic variant assessment | O | ||
Indent Indent81259-4 | Associated phenotype | O | 0..1 | |
Indent Indent53034-5 | Allelic state | C | 0..1 | |
Indent Indent81258-6 | Sample variant allelic frequency [NFr] | O | 0..1 | % |
Indent Indent82121-5 | Allelic read depth | O | 0..1 | {#} |
Indent Indent82120-7 | Allelic phase | O | 0..1 | |
Indent Indent82309-6 | Basis for allelic phase [Type] | O | ||
Indent81297-4 | Structural variant panel | |||
Indent Indent82155-3 | Genomic structural variant copy number | {#} | ||
Indent Indent81299-0 | Structural variant reported arrCGH [Ratio] | C | 0..1 | {Ratio} |
Indent Indent81300-6 | Structural variant [Length] | O | 0..1 | {#} |
Indent Indent81301-4 | Structural variant outer start and end | O | 0..1 | {Range} |
Indent Indent81302-2 | Structural variant inner start and end | O | 0..1 | {Range} |
Indent81251-1 | Complex genetic variant panel | 0..n | ||
Indent Indent81260-2 | Complex genetic variant [ID] | C | 0..1 | |
Indent Indent81262-8 | Complex variant HGVS name | C | 0..1 | |
Indent Indent81263-6 | Complex variant type | C | 0..1 | |
Indent Indent81259-4 | Associated phenotype | O | 0..1 | |
Indent Indent53037-8 | Genetic variation clinical significance [Imp] | O | 0..1 | |
Indent Indent53034-5 | Allelic state | O | 0..1 | |
Indent Indent82309-6 | Basis for allelic phase [Type] | O | ||
Indent Indent81250-3 | Discrete genetic variant panel | 0..n | ||
Indent Indent Indent83005-9 | Variant category | |||
Indent Indent Indent81252-9 | Discrete genetic variant | C | 0..1 | |
Indent Indent Indent48018-6 | Gene studied [ID] | C | 0..1 | |
Indent Indent Indent51958-7 | Transcript reference sequence [ID] | C | 0..1 | |
Indent Indent Indent48004-6 | DNA change (c.HGVS) | C | 0..1 | |
Indent Indent Indent48005-3 | Amino acid change (pHGVS) | C | 0..1 | |
Indent Indent Indent48019-4 | DNA change type | O | 0..1 | |
Indent Indent Indent48006-1 | Amino acid change [Type] | O | 0..1 | |
Indent Indent Indent48013-7 | Genomic reference sequence [ID] | C | 0..1 | |
Indent Indent Indent81290-9 | Genomic DNA change (gHGVS) | C | ||
Indent Indent Indent69547-8 | Genomic ref allele [ID] | C | 0..1 | |
Indent Indent Indent81254-5 | Genomic allele start-end | C | 0..1 | |
Indent Indent Indent69551-0 | Genomic alt allele [ID] | C | 0..1 | |
Indent Indent Indent84414-2 | Haplotype name | O | ||
Indent Indent Indent81255-2 | dbSNP [ID] | O | 0..1 | |
Indent Indent Indent81257-8 | CIGAR [ID] | O | 0..1 | |
Indent Indent Indent48001-2 | Cytogenetic (chromosome) location | O | 0..1 | |
Indent Indent Indent48002-0 | Genomic source class [Type] | O | 0..1 | |
Indent Indent Indent81304-8 | Variant analysis method [Type] | O | ||
Indent Indent Indent53037-8 | Genetic variation clinical significance [Imp] | O | 0..1 | |
Indent Indent Indent69548-6 | Genetic variant assessment | O | ||
Indent Indent Indent81259-4 | Associated phenotype | O | 0..1 | |
Indent Indent Indent53034-5 | Allelic state | C | 0..1 | |
Indent Indent Indent81258-6 | Sample variant allelic frequency [NFr] | O | 0..1 | % |
Indent Indent Indent82121-5 | Allelic read depth | O | 0..1 | {#} |
Indent Indent Indent82120-7 | Allelic phase | O | 0..1 | |
Indent Indent Indent82309-6 | Basis for allelic phase [Type] | O | ||
Indent82118-1 | Pharmacogenomics result panel | |||
Indent Indent48018-6 | Gene studied [ID] | 1..* | ||
Indent Indent84413-4 | Genotype display name | |||
Indent Indent53040-2 | Genetic variation's effect on drug metabolism | C | 0..1 | |
Indent Indent51961-1 | Genetic variation's effect on drug efficacy | C | 0..1 | |
Indent Indent83009-1 | Genetic variation's effect on high-risk allele | |||
Indent Indent82117-3 | Medication usage implications panel | O | 0..* | |
Indent Indent Indent51963-7 | Medication assessed [ID] | R | 1..* | |
Indent Indent Indent82116-5 | Medication usage suggestion [Type] | C | 1..1 | |
Indent Indent Indent83010-9 | Medication usage suggestion [Narrative] | C | ||
Indent83011-7 | Haplotype definition panel | |||
Indent Indent48018-6 | Gene studied [ID] | C | 0..1 | |
Indent Indent84414-2 | Haplotype name | O | ||
Indent Indent81250-3 | Discrete genetic variant panel | 0..n | ||
Indent Indent Indent83005-9 | Variant category | |||
Indent Indent Indent81252-9 | Discrete genetic variant | C | 0..1 | |
Indent Indent Indent48018-6 | Gene studied [ID] | C | 0..1 | |
Indent Indent Indent51958-7 | Transcript reference sequence [ID] | C | 0..1 | |
Indent Indent Indent48004-6 | DNA change (c.HGVS) | C | 0..1 | |
Indent Indent Indent48005-3 | Amino acid change (pHGVS) | C | 0..1 | |
Indent Indent Indent48019-4 | DNA change type | O | 0..1 | |
Indent Indent Indent48006-1 | Amino acid change [Type] | O | 0..1 | |
Indent Indent Indent48013-7 | Genomic reference sequence [ID] | C | 0..1 | |
Indent Indent Indent81290-9 | Genomic DNA change (gHGVS) | C | ||
Indent Indent Indent69547-8 | Genomic ref allele [ID] | C | 0..1 | |
Indent Indent Indent81254-5 | Genomic allele start-end | C | 0..1 | |
Indent Indent Indent69551-0 | Genomic alt allele [ID] | C | 0..1 | |
Indent Indent Indent84414-2 | Haplotype name | O | ||
Indent Indent Indent81255-2 | dbSNP [ID] | O | 0..1 | |
Indent Indent Indent81257-8 | CIGAR [ID] | O | 0..1 | |
Indent Indent Indent48001-2 | Cytogenetic (chromosome) location | O | 0..1 | |
Indent Indent Indent48002-0 | Genomic source class [Type] | O | 0..1 | |
Indent Indent Indent81304-8 | Variant analysis method [Type] | O | ||
Indent Indent Indent53037-8 | Genetic variation clinical significance [Imp] | O | 0..1 | |
Indent Indent Indent69548-6 | Genetic variant assessment | O | ||
Indent Indent Indent81259-4 | Associated phenotype | O | 0..1 | |
Indent Indent Indent53034-5 | Allelic state | C | 0..1 | |
Indent Indent Indent81258-6 | Sample variant allelic frequency [NFr] | O | 0..1 | % |
Indent Indent Indent82121-5 | Allelic read depth | O | 0..1 | {#} |
Indent Indent Indent82120-7 | Allelic phase | O | 0..1 | |
Indent Indent Indent82309-6 | Basis for allelic phase [Type] | O |
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.63
- Last Updated
- Version 2.66
- Order vs. Observation
- Both
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Aneuploidía cromosomas X e Y: |
es-MX | Spanish (Mexico) | Aneuploidía de los cromosomas X e Y: |
fr-FR | French (France) | Chromosome X et Y aneuploïdie: |
it-IT | Italian (Italy) | Cromosomi X & Y, aneuploidia: Synonyms: Aneuploidia dei cromosomi X e Y Ibridazione in situ fluorescente (FISH) Osservazione Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
nl-NL | Dutch (Netherlands) | chromosoom X & Y aneuploïdie: |
pl-PL | Polish (Poland) | Aneuploidia chromosomów X & Y: Synonyms: Aneuploidia chromosomów X i Y |
tr-TR | Turkish (Turkey) | Kromozom X ve Y anöploidi: |
zh-CN | Chinese (China) | 染色体 X 与 Y 非整倍体性: Synonyms: Fluorescent in situ hybridization; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=87436-2
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright